Viking Therapeutics Faces Mounting Losses Amid Aggressive Drug Development Push
Investors in Viking Therapeutics were met with sobering financial results for the third quarter of 2025, as the biotechnology firm...
My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers.
My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world.
A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses.
In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.
Investors in Viking Therapeutics were met with sobering financial results for the third quarter of 2025, as the biotechnology firm...
Eli Lilly delivered a stunning financial performance that exceeded even the most optimistic market forecasts when it released quarterly results...
Franklin Resources (NYSE: BEN) approaches a pivotal moment as it prepares to release its quarterly financial results on November 7th....
The proposed acquisition of Cantaloupe by 365 Retail Markets has encountered significant delays, pushing the expected completion timeline into the...
KeyCorp finds itself confronting a challenging market paradox: delivering robust quarterly results while struggling to overcome persistent investor wariness toward...
Insperity finds itself navigating turbulent legal and financial waters as a prominent shareholder rights firm initiates an investigation into the...
Middlesex Water Company faces a critical test of its financial resilience as recent quarterly performance reveals significant operational challenges. While...
Stoke Therapeutics equity faced substantial selling pressure as new clinical trial results triggered a sharp decline in its market value....
Richardson Electronics witnessed a dramatic surge in its share price following unexpectedly robust quarterly results that far exceeded market expectations....
Insight finds itself in a severe downturn, with its equity value deteriorating rapidly following a trifecta of negative developments. The...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com